JAQC .85 - This is the initial stage and this can be a sure long term hold with so much room to grow. JAQC has a huge merger with Russian based Pharmaceutical co Rafarma. They are Russia's largest Pharmaceutical co and have over 100 different drugs.
This could easily be multi dollars in the future.imo Probably a 10 bagger from these current levels. The current value(not reflected in pps as of yet) is over $4.00 a share. The potential here is just mind boggling. This is a type of merger one waits a lifetime for and now its here and at a ground floor opportunity for investors.
Here are some highlights.
Some highlights:
- Only 420K float
- Plant will single handily reduce Russia's foreign drug imports by 30%
- Russian government holds most of the control of the company in its hands
- Funding of the construction of the plant came straight from Vladimir Putin
- Company has been conservatively valued at circa US$300 million.
- Projected Revenues...2012-$15,606,285, 2013-$142,488,845, 2014-$271,488,845
- Will produce 200 different drugs, a mixture of both generics and proprietary medicines, which have already gone through human clinical trials and are ready to go right now.
- Only pharma plant in Russia that is fully compliant with the complete cycle of the world's top pharmaceutical standards.
- Rafarma is a contract manufacture for companies like Abbott, Bristol Myers, Novartis, GlaxoSmithKline, Merck, Roche and BayerAG.
- By 2014 they will have a whopping 33% of the market share in Russia and Eastern Europe for many drugs they produce.
My posts are only my opinion. I don't know the future. Please don't take my posts as investment decisions. You have to do your own Due Diligence and make your own investment choices.